CoV19™ Prognostic Screening Tool
909 Healthcare, in collaboration with George Mason University, has developed and launched an evidenced-based prognostic screening tool for COVID-19. CoV19™ is a probability assessment that provides early and accurate evaluation of an individual's likelihood of contracting active COVID-19 and differentiates between influenza and influenza-like illnesses...for both symptomatic and asymptomatic individuals.
CoV19™ Introduction PDF
CoV19™ PST Guest Survey
CoV19™ Introduction Video
Schedule a Demo MDiQ provides FDA authorized at-home COVID-19 testing kits with fast results within 24-48 hours of testing.
Our Partners
